4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-19-056807
SVP, COO & CFO sold 25,000 shares at $19.79 ($494,750)
- SVP, COO & CFO acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Labrucherie Gil M · SVP, COO & CFO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-11-13 | Exercise or conversion : show line 1 in the form | +25,000 | $7.21 | $180,250 | 252,872 | D |
| 2019-11-13 | Sale : show line 2 in the form | −25,000 | $19.79 | $494,750 | 227,872 | D |
| Open-market sales · 25,000 sh · avg $19.79 · $494,750 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-11-13 | Exercise or conversion : show line 3 in the form Stock Option | −25,000 | 0 | D |
Loading xslF345X03/doc4.xml…